Tag Archives: United States

Congress can codify sensible National Institutes of Health research rules

THE SWIRL of controversy that greeted President Obama’s executive order lifting the ban on federal funding of stem cell research in March didn’t make a significant return when the final rules were released over the summer. That’s because the National Institutes of Health successfully navigated a minefield of ethical and moral questions. To protect those regulations from politics and changes by another administration, Rep. Diana DeGette (D-Colo.) soon will introduce the Stem Cell Research Enhancement Act of 2009. The legislation would codify Mr. Obama’s executive order permitting federal funding of such research within guidelines established by the NIH and
Read More…

VATICAN – Stem cells. Osservatore Romano: Obama uses public money to kill human beings

Image by p!o via Flickr

“For the first time, taxpayer money will be used to kill human beings in the embryonic state in order to harvest stem cells,” wrote the Osservatore Romano newspaper, which underlined how this is the result of new guidelines “after President Barack Obama overturned a decision by the Bush administration banning publically funded stem cell research”.

The Vatican newspaper cited the website of the Episcopal Conference of the United States which said “this is a new chapter in the division between biomedical research and its necessary ethical basis, the respect for human life at all stages.”
Read More…

ITALY – Cattaneo: Italy will become a parasite feeding on the US

Image via Wikipedia

After US President Barack Obama opened up to embryonic stem cell research, “we will have an America that will begin to run ,and an Italy that risks becoming a parasite,” were the fears expressed by pharmacologist Elena Cattaneo, director of the stem cell research center of the University of Milan.

Obama’s attitude, observed the Italian researcher today during a meeting in Milan, “is very positive. He has opened the door to research,” she said to Adnkronos Salute, “but with caution, without crying miracle. With the idea that perhaps tomorrow future generations will be able to benefit
Read More…

Novocell announces patent on insulin-producing stem-cell technique

Image via Wikipedia

SAN DIEGO – Novocell, a small, privately held San Diego company, may have found new ways to make money from its technique for coaxing human embryonic stem cells into insulin-producing pancreatic cells.
That’s good news in a field that has had trouble attracting investor funding. Many venture capital firms have been skittish because of politics and the nascency of the embryonic stem cell science.

The biotechnology company announced Tuesday that it received a patent that essentially gives it control over all endoderm cells made from human embryonic stem cells.
Endoderm cells are precursor cells that can eventually develop into cells
Read More…